VitaSpring Biomedical Co. Ltd. (VSBC) stock
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $6.58MP/E –Yield –
VitaSpring Biomedical r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for VitaSpring Biomedical
VitaSpring Biomedical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?